Published in Pediatr Infect Dis on March 06, 1985
Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for detection of fungemia in children. J Clin Microbiol (1996) 1.13
Rapid detection of bacteremia in children with a modified lysis direct plating method. J Clin Microbiol (1985) 1.12
Comparison of the Du Pont Isolator 1.5 Microbial Tube and Trypticase soy broth for the recovery of Haemophilus influenzae type b in experimental bacteremia. J Clin Microbiol (1985) 0.80
A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74
Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20
Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J (1990) 1.98
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73
The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72
Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61
Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61
Routine viral culture for pediatric respiratory specimens submitted for direct immunofluorescence testing. J Clin Microbiol (1989) 1.61
Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50
Second episodes of Haemophilus influenzae type b disease following rifampin prophylaxis of the index patients. Pediatr Infect Dis J (1987) 1.47
Vitamin A levels in children with measles in Long Beach, California. J Pediatr (1992) 1.42
Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40
Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39
Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34
Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med (1984) 1.32
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24
Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila) (1993) 1.21
Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr (1992) 1.20
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
Single-dose pharmacokinetics of aztreonam in pediatric patients. Antimicrob Agents Chemother (1984) 1.16
Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12
In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother (1985) 1.12
Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11
Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07
Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06
Bacterial arthritis caused by Corynebacterium diphtheriae. Pediatr Infect Dis J (1993) 1.02
Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol (1990) 1.00
Polymerase chain reaction for diagnosis of M. tuberculosis: comparison of simple boiling and a conventional method for DNA extraction. Biochem Mol Med (1996) 1.00
Fasle-positive macroscopic appearance of blood cultures in sorbitol-containing hypertonic medium. J Clin Microbiol (1979) 0.98
Recognition of Staphylococcus saprophyticus in urine cultures by screening colonies for production of phosphatase. J Clin Microbiol (1985) 0.96
Cat scratch disease: the rare role of Afipia felis. J Clin Microbiol (1998) 0.94
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum. Antimicrob Agents Chemother (1990) 0.93
A multicenter comparison of related pharmacologic features of cephalexin and dicloxacillin given for two months to young children with cystic fibrosis. Pediatr Pharmacol (New York) (1985) 0.93
Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis (1986) 0.92
Campylobacter enteritis. A 3-year experience. Clin Pediatr (Phila) (1984) 0.91
Sputum screening by Nomarski interference contrast microscopy. J Clin Microbiol (1979) 0.91
Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis. Am J Dis Child (1992) 0.90
Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother (1987) 0.90
Catalase-negative listeria monocytogenes causing meningitis in an adult. Clinical and laboratory features. Am J Clin Pathol (1991) 0.89
Neutralization of the inhibitory effect of sodium polyanetholesulfonate on Neisseria meningitidis in blood cultures processed with the Du Pont Isolator System. J Clin Microbiol (1984) 0.89
Evaluation of the automated Bact-Alert system for pediatric blood culturing. Am J Clin Pathol (1995) 0.88
Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. Am J Med (1987) 0.88
Morphologically variable bacilli of cat scratch disease are identified by immunocytochemical labeling with antibodies to Rochalimaea henselae. Am J Clin Pathol (1994) 0.86
In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients. Antimicrob Agents Chemother (1992) 0.86
Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion. Pediatr Infect Dis J (1991) 0.85
Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Vet Immunol Immunopathol (1999) 0.85
Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients. Pediatr Pharmacol (New York) (1986) 0.85
Evaluation of an enzyme immunoassay for detection of Neisseria gonorrhoeae in an adolescent population. JAMA (1984) 0.84
Invasive Haemophilus influenzae type B infections: a continuing challenge. Am J Infect Control (1990) 0.84
Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis. Am J Med (1987) 0.84
Diagnosis of bacterial infections of the newborn infant. Clin Perinatol (1981) 0.84
Comparison of quantitative polymerase chain reaction, acid fast bacilli smear, and culture results in patients receiving therapy for pulmonary tuberculosis. Diagn Microbiol Infect Dis (1997) 0.83
Phaeohyphomycosis of the maxilloethmoid sinus caused by Drechslera spicifera: a new fungal pathogen. Laryngoscope (1984) 0.83
Middle ear effusion amoxicillin concentrations in acute otitis media. Pediatr Infect Dis J (1998) 0.83
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients. Antimicrob Agents Chemother (1984) 0.82
In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputum. Diagn Microbiol Infect Dis (1992) 0.81
Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations. Antimicrob Agents Chemother (1982) 0.80
Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group. Pediatr Infect Dis J (1995) 0.80
Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics. Antimicrob Agents Chemother (1983) 0.80
Chlamydia trachomatis as a cause of pneumonitis and pleural effusion. J Pediatr (1984) 0.80
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates. Pediatrics (1985) 0.80
Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin. Clin Ther (1980) 0.80
Current issues in burn wound infections. Adv Pediatr Infect Dis (1991) 0.79
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (1990) 0.79
In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid. J Antimicrob Chemother (1991) 0.78
Aztreonam therapy for serious gram-negative infections in children. Am J Dis Child (1986) 0.78
Hemophilus influenzae type b meningitis in infant rabbits. Pathogenesis and therapy. Am J Dis Child (1984) 0.78
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin. Chemotherapy (1982) 0.77
Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae. Clin Rev Allergy (1991) 0.77
Protozoal colonization of the intestinal tract in institutionalized Romanian children. Clin Infect Dis (1996) 0.76
Aeromonas species in aquaria: a reservoir of gastrointestinal infections? J Hosp Infect (1989) 0.76
Parainfluenza type 3 meningitis. Report of two cases and review of the literature. Clin Pediatr (Phila) (1990) 0.76
Diagnosis of tuberculosis: can the polymerase chain reaction replace acid-fast bacilli smear and culture? J Infect Dis (1995) 0.75
Detection of anti-BCG secreting cells in cerebrospinal fluid. Lancet (1990) 0.75
Quantitative-competitive polymerase chain reaction for rapid susceptibility testing of Mycobacterium tuberculosis to isoniazid. Biochem Mol Med (1997) 0.75
Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J (1993) 0.75
Modal analysis of linear Talbot-cavity semiconductor lasers. Opt Lett (1991) 0.75
Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia. J Antimicrob Chemother (1985) 0.75
Serratia osteochondritis after puncture wounds of the foot. Pediatr Infect Dis J (1990) 0.75
Broadly tunable laser-diode-based mid-infrared source with up to 31 microW of power at 4.3-microm wavelength. Opt Lett (1996) 0.75
Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae. Chemotherapy (1989) 0.75